Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orchard Secures New Libmeldy Price In Germany

May 05 2022

• By Francesca Bruce

Germany Flag Money — Orchard Therapeutics welcomes new pricing deal for Libmeldy in Germany • Source: Alamy

Related Content

Libmeldy: ‘Significant Discount’ For World’s Most Expensive Drug Secures English Funding

Feb 04 2022

Gene Therapy Libmeldy Undergoes Cross-Country HTA In Europe

Mar 04 2022

Germany To Honor Pledge To Cut Spending On Medicines

Mar 17 2022

Related Companies

Orchard Therapeutics Limited

Additional Topics

Europe Germany Health Technology Assessment Market Access Policy Pricing Debate Pricing Strategies Rare Diseases Reimbursement BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.